Published in N Engl J Med on November 12, 2014
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. Clin Infect Dis (2015) 3.83
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med (2016) 2.88
Ebola virus disease. BMJ (2014) 2.63
Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit. Intensive Care Med (2015) 2.05
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses (2014) 1.73
Pre-hospital transportation in Western countries for Ebola patients, comparison of guidelines. Intensive Care Med (2015) 1.54
Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A (2015) 1.49
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47
Ebola Virus Infection among Western Healthcare Workers Unable to Recall the Transmission Route. Biomed Res Int (2016) 1.40
Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med (2016) 1.15
Treatment of Ebola. N Engl J Med (2015) 1.12
Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med (2015) 1.06
Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection. J Infect Dis (2015) 1.06
Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection. Dig Dis Sci (2015) 1.06
Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control. Epidemiol Infect (2016) 1.02
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency. Clin Infect Dis (2015) 1.01
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. J Virol (2015) 1.00
Use of the FilmArray System for Detection of Zaire ebolavirus in a Small Hospital in Bo, Sierra Leone. J Clin Microbiol (2015) 0.97
Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa. PLoS Med (2015) 0.97
Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens. J Clin Microbiol (2015) 0.97
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers. MBio (2015) 0.97
Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma. J Infect Dis (2015) 0.95
Discovery of an antibody for pan-ebolavirus therapy. Sci Rep (2016) 0.93
Loperamide therapy for voluminous diarrhea in Ebola virus disease. J Infect Dis (2015) 0.93
Out of Africa--caring for patients with Ebola. N Engl J Med (2014) 0.92
Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin Microbiol Rev (2015) 0.92
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field. Clin Infect Dis (2015) 0.92
Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease. J Infect Dis (2015) 0.92
Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosens Bioelectron (2015) 0.91
Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection. Obstet Gynecol (2015) 0.89
Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review. PLoS Negl Trop Dis (2016) 0.88
Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States. Crit Care Med (2015) 0.88
Experimental Treatment of Ebola Virus Disease with Brincidofovir. PLoS One (2016) 0.88
Ebola virus disease complicated with viral interstitial pneumonia: a case report. BMC Infect Dis (2015) 0.88
Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review. Clin Infect Dis (2015) 0.86
Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease. Clin Infect Dis (2016) 0.84
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection. Cell Death Dis (2016) 0.84
Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther (2015) 0.83
Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat Immunol (2016) 0.82
Ebola virus disease and critical illness. Crit Care (2016) 0.82
Neurological Complications of Ebola Virus Infection. Neurotherapeutics (2016) 0.81
Ebola virus disease: What clinicians in the United States need to know. Am J Infect Control (2015) 0.81
Ebola Virus RNA Stability in Human Blood and Urine in West Africa's Environmental Conditions. Emerg Infect Dis (2016) 0.81
Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses. Clin Vaccine Immunol (2016) 0.80
The potential of plants as a system for the development and production of human biologics. F1000Res (2016) 0.80
Hospital Preparations for Viral Hemorrhagic Fever Patients and Experience Gained from Admission of an Ebola Patient. Emerg Infect Dis (2016) 0.80
Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone. J Infect Dis (2016) 0.79
Filoviruses: One of These Things is (not) Like the Other. Viruses (2015) 0.78
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus. Genome Biol (2017) 0.78
Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School. J Virol (2015) 0.78
Treatment of Ebola. N Engl J Med (2015) 0.78
An Ebola virus-encoded microRNA-like fragment serves as a biomarker for early diagnosis of Ebola virus disease. Cell Res (2016) 0.78
Potent neutralizing monoclonal antibodies against Ebola virus infection. Sci Rep (2016) 0.77
Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol (2017) 0.77
Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS). Emerg Microbes Infect (2015) 0.76
Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection. Sci Rep (2016) 0.76
Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis. PLoS Pathog (2015) 0.76
Lassa fever: another threat from West Africa. Disaster Mil Med (2016) 0.75
Ebola and cholera. Am J Trop Med Hyg (2015) 0.75
Anemia during Hospitalization in the Patients with Ebola Virus Disease. Iran J Pathol (2016) 0.75
Ebola: Implications and Perspectives. Trans Am Clin Climatol Assoc (2015) 0.75
When Potentially Lifesaving Drugs are Both Experimental and in Very Short Supply: A Clinician's Story from the Front Lines of the Battle Against Ebola. Am J Trop Med Hyg (2015) 0.75
Responding to the Global Threat of High-Consequence Pathogens: Protecting Health Care Workers and Caring for Patients. Ann Am Thorac Soc (2016) 0.75
Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea. JCI Insight (2017) 0.75
Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci Rep (2017) 0.75
Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus). PLoS One (2016) 0.75
A Health Care Worker with Ebola Virus Disease and Adverse Prognostic Factors Treated in Sierra Leone. Am J Trop Med Hyg (2016) 0.75
U.S. Ebola Treatment Center Clinical Laboratory Support. J Clin Microbiol (2016) 0.75
Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015. Emerg Infect Dis (2016) 0.75
Understanding bleeding in ebola virus disease. Clin Adv Hematol Oncol (2015) 0.75
Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us. Microbiol Spectr (2016) 0.75
Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res (2017) 0.75
DNA immunization as a technology platform for monoclonal antibody induction. Emerg Microbes Infect (2016) 0.75
Ebola or Not? Evaluating the Ill Traveler From Ebola-Affected Countries in West Africa. Open Forum Infect Dis (2016) 0.75
Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles. PLoS One (2016) 0.75
Ebola virus disease: Essential clinical knowledge. Avicenna J Med (2017) 0.75
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02
Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52
Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis (2007) 6.46
Systems biology of vaccination for seasonal influenza in humans. Nat Immunol (2011) 6.09
Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80
Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med (2009) 5.68
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 5.19
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01
Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69
Discovery of swine as a host for the Reston ebolavirus. Science (2009) 3.68
Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 3.50
2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32
Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010) 3.29
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2002) 3.27
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A (2012) 3.27
Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis (2012) 3.19
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med (2012) 3.05
Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. J Infect Dis (2009) 3.05
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99
Low frequency of poultry-to-human H5NI virus transmission, southern Cambodia, 2005. Emerg Infect Dis (2006) 2.98
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2003) 2.96
Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis (2009) 2.82
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79
Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med (2015) 2.71
Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71
Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol (2010) 2.69
Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem (2006) 2.56
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51
Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis (2009) 2.50
Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48
Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med (2010) 2.47
Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror (2006) 2.43
Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis (2013) 2.38
Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerg Infect Dis (2008) 2.38
Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis (2010) 2.36
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine (2008) 2.33
Seasonality, timing, and climate drivers of influenza activity worldwide. J Infect Dis (2012) 2.30
Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One (2008) 2.28
Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. PLoS Genet (2011) 2.10
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics (2004) 2.08
Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One (2008) 2.04
Family clustering of avian influenza A (H5N1). Emerg Infect Dis (2005) 2.04
What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol (2014) 2.04
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med (2012) 2.00
A 68-Year-Old Musician With Cough, Wheezing, and a Lung Mass. Chest (2015) 2.00
Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med (2009) 1.99
Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis (2007) 1.98
Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J Virol (2008) 1.96
Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis (2007) 1.95
Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. J Virol (2008) 1.93
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis (2011) 1.87
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis (2007) 1.85
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol (2006) 1.85
Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One (2009) 1.83
The burden of influenza in East and South-East Asia: a review of the English language literature. Influenza Other Respir Viruses (2008) 1.79
Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis (2010) 1.75
Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J Virol (2012) 1.74
Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics (2011) 1.74
Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J (2004) 1.73
Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol (2011) 1.73
Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006. Emerg Infect Dis (2007) 1.71
Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis (2006) 1.69
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62
Care of the child with Ebola virus disease. Pediatr Crit Care Med (2015) 1.62
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Emerg Infect Dis (2016) 1.62
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol (2005) 1.61
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis (2006) 1.57
Aerosol transmission is an important mode of influenza A virus spread. Nat Commun (2013) 1.56
A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis (2005) 1.56
Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*. Pediatr Crit Care Med (2012) 1.56
Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol (2006) 1.55